<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00005364</url>
  </required_header>
  <id_info>
    <org_study_id>4251</org_study_id>
    <secondary_id>R01HL049074</secondary_id>
    <nct_id>NCT00005364</nct_id>
  </id_info>
  <brief_title>Genetic Epidemiology of CHD Risk Factors in Blacks</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Heart, Lung, and Blood Institute (NHLBI)</source>
  <brief_summary>
    <textblock>
      To determine the genetic epidemiology of coronary heart disease (CHD) risk factors in Blacks.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      DESIGN NARRATIVE:

      The study used two well defined African populations from Nigeria to determine the
      contribution of 14 polymorphic genes involved in lipid metabolism in determining quantitative
      lipoprotein-lipid and apolipoprotein levels as these are major risk factors for coronary
      heart disease. The study also investigated how differences in life styles and dietary habits
      modulate the genetic contribution of these quantitative risk factors. Phenotypes in the gene
      products of APOs A-IV, C-II, D, H, J and (a) were determined by IEF and SDS/immunoblotting.
      Genotypes at the B,E, AI-CIII- AIV cluster, lipoprotein lipase, hepatic lipase, LDL-receptor,
      and cholesterol ester transfer protein were determined by polymerase chain reaction
      protocols. The quantitative levels of total cholesterol, HDL-cholesterol and its
      subfractions, HDL2- and HDL3-cholesterol, triglycerides and LP(a) were used in the genetic
      analyses. Estimates of the effect of alleles at each of the candidate loci on quantitative
      lipoprotein-lipid levels employed the measured genotype approach. The effect of multisite
      haplotypes for RFLP at various loci, where applicable, was also estimated using the same
      method. The interaction of alleles at various independent loci in determining quantitative
      lipoprotein-lipid and apolipoprotein levels was estimated. In addition to the measurements of
      environmental effects, measurements were also made of the genotype-environmental interaction
      in determining quantitative risk factor traits.

      The study completion date listed in this record was obtained from the &quot;End Date&quot; entered in
      the Protocol Registration and Results System (PRS) record.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 1994</start_date>
  <completion_date type="Actual">March 1999</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <condition>Cardiovascular Diseases</condition>
  <condition>Heart Diseases</condition>
  <condition>Coronary Disease</condition>
  <eligibility>
    <criteria>
      <textblock>
        No eligibility criteria
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <reference>
    <citation>Anderson JL, Bunker CH, Aston CE, Kamboh MI. Relationship of two apolipoprotein B polymorphisms with serum lipoprotein and lipid levels in African blacks. Hum Biol. 1997 Dec;69(6):793-807.</citation>
    <PMID>9353975</PMID>
  </reference>
  <reference>
    <citation>Saha N, Wang G, Vasisht S, Kamboh MI. Influence of two apo A4 polymorphisms at codons 347 and 360 on non-fasting plasma lipoprotein-lipids and apolipoproteins in Asian Indians. Atherosclerosis. 1997 Jun;131(2):249-55.</citation>
    <PMID>9199279</PMID>
  </reference>
  <reference>
    <citation>Kamboh MI, Sanghera DK, Aston CE, Bunker CH, Hamman RF, Ferrell RE, DeKosky ST. Gender-specific nonrandom association between the alpha 1-antichymotrypsin and apolipoprotein E polymorphisms in the general population and its implication for the risk of Alzheimer's disease. Genet Epidemiol. 1997;14(2):169-80.</citation>
    <PMID>9129962</PMID>
  </reference>
  <reference>
    <citation>Sanghera DK, Saha N, Aston CE, Kamboh MI. Genetic polymorphism of paraoxonase and the risk of coronary heart disease. Arterioscler Thromb Vasc Biol. 1997 Jun;17(6):1067-73.</citation>
    <PMID>9194756</PMID>
  </reference>
  <reference>
    <citation>Evans RW, Sankey SS, Hauth BA, Sutton-Tyrrell K, Kamboh MI, Kuller LH. Effect of sample storage on quantitation of lipoprotein(a) by an enzyme-linked immunosorbent assay. Lipids. 1996 Nov;31(11):1197-203.</citation>
    <PMID>8934453</PMID>
  </reference>
  <reference>
    <citation>Harris M, Sanghera DK, Kamboh MI. Short report on DNA marker at candidate locus. Two new alleles in the tetranucleotide repeat polymorphism in the LDL-receptor-related protein (LRP) gene. Clin Genet. 1996 Jul;50(1):54-5.</citation>
    <PMID>8891388</PMID>
  </reference>
  <reference>
    <citation>Kamboh MI, Evans RW, Aston CE. Genetic effect of apolipoprotein(a) and apolipoprotein E polymorphisms on plasma quantitative risk factors for coronary heart disease in American black women. Atherosclerosis. 1995 Sep;117(1):73-81.</citation>
    <PMID>8546757</PMID>
  </reference>
  <reference>
    <citation>Kamboh MI, Aston CE, Hamman RF. The relationship of APOE polymorphism and cholesterol levels in normoglycemic and diabetic subjects in a biethnic population from the San Luis Valley, Colorado. Atherosclerosis. 1995 Jan 20;112(2):145-59.</citation>
    <PMID>7772075</PMID>
  </reference>
  <reference>
    <citation>Islam S, Gutin B, Smith C, Treiber F, Kamboh MI. Association of apolipoprotein(a) phenotypes in children with family history of premature coronary artery disease. Arterioscler Thromb. 1994 Oct;14(10):1609-16.</citation>
    <PMID>7918311</PMID>
  </reference>
  <reference>
    <citation>Sanghera DK, Aston CE, Saha N, Kamboh MI. DNA polymorphisms in two paraoxonase genes (PON1 and PON2) are associated with the risk of coronary heart disease. Am J Hum Genet. 1998 Jan;62(1):36-44.</citation>
    <PMID>9443862</PMID>
  </reference>
  <reference>
    <citation>Sanghera DK, Saha N, Kamboh MI. The codon 55 polymorphism in the paraoxonase 1 gene is not associated with the risk of coronary heart disease in Asian Indians and Chinese. Atherosclerosis. 1998 Feb;136(2):217-23.</citation>
    <PMID>9543091</PMID>
  </reference>
  <reference>
    <citation>Ali S, Bunker CH, Aston CE, Ukoli FA, Kamboh MI. Apolipoprotein A kringle 4 polymorphism and serum lipoprotein (a) concentrations in African blacks. Hum Biol. 1998 Jun;70(3):477-90.</citation>
    <PMID>9599940</PMID>
  </reference>
  <reference>
    <citation>Harris MR, Bunker CH, Hamman RF, Sanghera DK, Aston CE, Kamboh MI. Racial differences in the distribution of a low density lipoprotein receptor-related protein (LRP) polymorphism and its association with serum lipoprotein, lipid and apolipoprotein levels. Atherosclerosis. 1998 Mar;137(1):187-95.</citation>
    <PMID>9568751</PMID>
  </reference>
  <reference>
    <citation>Nestlerode CS, Bunker CH, Sanghera DK, Aston CE, Ukoli FA, Kamboh MI. Apolipoprotein J polymorphisms and serum HDL cholesterol levels in African blacks. Hum Biol. 1999 Apr;71(2):197-218.</citation>
    <PMID>10222643</PMID>
  </reference>
  <reference>
    <citation>Kamboh MI, Bunker CH, Aston CE, Nestlerode CS, McAllister AE, Ukoli FA. Genetic association of five apolipoprotein polymorphisms with serum lipoprotein-lipid levels in African blacks. Genet Epidemiol. 1999;16(2):205-22.</citation>
    <PMID>10030402</PMID>
  </reference>
  <reference>
    <citation>Kamboh MI. Apolipoprotein E polymorphism and susceptibility to Alzheimer's disease. Hum Biol. 1995 Apr;67(2):195-215. Review.</citation>
    <PMID>7729825</PMID>
  </reference>
  <verification_date>June 2000</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 25, 2000</study_first_submitted>
  <study_first_submitted_qc>May 25, 2000</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 26, 2000</study_first_posted>
  <last_update_submitted>May 12, 2016</last_update_submitted>
  <last_update_submitted_qc>May 12, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 13, 2016</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

